E&G Advisors, LP
- SEC CIK
- 0001598550
- Latest filing
- Jul 23, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by E&G Advisors, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −291−100.0% | Sold out | Holders |
| Q4 2024 | 291 | $207.3K | 0.1% | −10−3.3% | Reduced | Holders |
| Q3 2024 | 301 | $316.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 301 | $316.4K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 301 | $289.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 301 | $264.4K | 0.1% | −4−1.3% | Reduced | Holders |
| Q3 2023 | 305 | $251.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 305 | $219.2K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 305 | $250.6K | 0.1% | −5−1.6% | Reduced | Holders |
| Q4 2022 | 310 | $223.7K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 310 | $214.0K | 0.1% | +310 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −310−100.0% | Sold out | Holders |
| Q1 2022 | 310 | $217.0K | 0.1% | +310 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | 0 | Sold out | Holders |
| Q2 2021 | 0 | $235.0K | 0.1% | 0 | New | Holders |